Jurayev J.S.,, Jurayev J.S.,, Karshiev.M.A, Karshiev.M.A, Uralov A.A, Uralov A.A (2024) RECURRENCE OF CHCV AFTER THE USE OF DIRECT ANTIVIRAL DRUGS: CLINICS, DIAGNOSIS, TREATMENT AND OUTCOMES. INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION, 1 (4). pp. 98-99.
![[thumbnail of Jurayev_J.S._98-99.pdf]](https://arxiv.universalpublishings.com/style/images/fileicons/application_pdf.png)
PDF
Jurayev_J.S._98-99.pdf - Published Version
Download (166kB)
Annotatsiya
Viral hepatitis C is one of the leading liver diseases. According to WHO, 70 million people are infected with this disease. HCV kills 290,000 people every year. In 95% of patients, the disease becomes chronic, and the main complications are fibrosis and cirrhosis of the liver. In some cases, a relapse is observed, despite treatment with antiviral drugs.
| Hujjat turi: | Maqola |
|---|---|
| Mualliflar: | Muallif Email Jurayev J.S.,, Jurayev J.S., UNSPECIFIED Karshiev.M.A, Karshiev.M.A UNSPECIFIED Uralov A.A, Uralov A.A UNSPECIFIED |
| Jurnal / Nashr: | INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION |
| Jild: | 1 |
| Soni: | 4 |
| Sahifalar: | pp. 98-99 |
| Sana: | 12 May 2024 |
| Kalit so'zlar: | extrahepatic manifestations, relapse, IFN + riboverine, retreatment of relapse HCV RNA genotype 1b. |
| URI: | https://arxiv.universalpublishings.com/id/eprint/97684 |
![[pin missing: title]](/style/images/action_view.png)
- [pin missing: title]